Abstract B19: Fetal lung adenocarcinoma: Characterization of primary cell culture and in vitro drug response

2012 ◽  
Vol 18 (3 Supplement) ◽  
pp. B19-B19
Author(s):  
Cecilia Menna ◽  
Mohsen Ibrahim ◽  
Daniela Peruzzi ◽  
Luca Pacini ◽  
Michela Ciancamerla ◽  
...  
2016 ◽  
Vol 36 (9) ◽  
pp. 844-850 ◽  
Author(s):  
Luis M.M. Flórez ◽  
Haline F. Ballestero ◽  
Anderson P. Duzanski ◽  
Paulo R.O. Bersano ◽  
João F. Lima ◽  
...  

Abstract: Immunochemistry with anti-vimentin, anti-lysozyme, anti-alpha 1 antitrypsin, anti-CD3 and anti-CD79α antibodies has been used for characterization of primary cell culture in the transmissible venereal tumor (TVT). Samples for primary cell culture and immunohistochemistry assays were taken from eight dogs with cytological and clinical diagnosis of TVT. To validate the immunochemical results in the primary cell culture of TVT, a chromosome count was performed. For the statistical analysis, the Mann-Whitney test with p<0.05 was used. TVT tissues and culture cells showed intense anti-vimentin immunoreactivity, lightly to moderate immunoreactivity for anti-lysozyme, and mild for anti-alpha-antitrypsin. No marking was achieved for CD3 and CD79α. All culture cells showed chromosomes variable number of 56 to 68. This is the first report on the use of immunocytochemical characterization in cell culture of TVT. Significant statistic difference between immunochemistry in tissue and culture cell was not established, what suggests that the use of this technique may provide greater certainty for the confirmation of tumors in the primary culture. This fact is particularly important because in vitro culture of tumor tissues has been increasingly used to provide quick access to drug efficacy and presents relevant information to identify potential response to anticancer medicine; so it is possible to understand the behavior of the tumor.


BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
L. Ehlen ◽  
J. Arndt ◽  
D. Treue ◽  
P. Bischoff ◽  
F. N. Loch ◽  
...  

1988 ◽  
Vol 105 (4) ◽  
pp. 580-582
Author(s):  
I. S. Komolov ◽  
V. P. Fedotov ◽  
D. Rappay ◽  
I. Fazekas ◽  
V. V. Abramova ◽  
...  

2017 ◽  
Author(s):  
Alfred Simental ◽  
Steve Lee ◽  
Pedro A. De Andrade Filho ◽  
Nathaniel R. Peterson ◽  
Saied Mirshahidi ◽  
...  

2002 ◽  
Vol 13 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Christine B. Bratka-Robia ◽  
Gerda Mitteregger ◽  
Amanda Aichinger ◽  
Monika Egerbacher ◽  
Magdalena Helmreich ◽  
...  

2012 ◽  
Vol 23 (2) ◽  
pp. 218-230 ◽  
Author(s):  
R.E. Adamson ◽  
A.A. Frazier ◽  
H. Evans ◽  
K.F. Chambers ◽  
E. Schenk ◽  
...  

1983 ◽  
Vol 3 (2) ◽  
pp. 189-194 ◽  
Author(s):  
A. Słominski

Transfer of Bomirski amelanotic melanoma ceils from in vivo to in vitro growth conditions results in occurrence of rapid melanization in their cytoplasm. The melanized ceils from primary cell culture initiate tumours in hamsters, which do not contain traces of melanin and resemble typical amelanotic melanoma.


2020 ◽  
Vol 50 (11) ◽  
Author(s):  
Haline Ballestero Fêo ◽  
Luis Mauricio Montoya Flórez ◽  
Ricardo Seiti Yamatogi ◽  
Anderson do Prado Duzanski ◽  
João Pessoa Araújo Junior ◽  
...  

ABSTRACT: Canine transmissible venereal tumor (CTVT) is a transmissible neoplasm, which spreads naturally between dogs through the halogenic transfer of tumor cells, mainly during coitus. It is the oldest known tumoral lineage in nature and reports on gene mutations have been extended. Also, this tumor shares several genetic mutations with some cancers in humans, among them lung carcinomas, melanoma, prostate, breast, among other cancers. Thus, expression of tumor suppressor genes such as TP53, P21, and apoptosis-related genes such as BAX, BCL-2, and BCL-xL, both in vivo and in vitro (primary cell culture) were quantified. In the present study, the comparison of gene expression, the TP53 gene, in most cases, was shown to be high in the majority of tissues (65%) and primary cell culture (100%), while BCL-2, BCL-xL, and BAX presented variation among the animals analyzed. Moreover, in these situations, the results suggested that the apoptotic regulation of these genes did not occur for TP53. The P21 gene was shown to be mostly normal (70%); although, absence (6%) and underexpressions (24%) were also observed. Statistical analysis of the BCL-xL gene demonstrated significant differences between the tissues of the animals when compared to the cell cultures; however, to the other genes, no statistical difference was observed between the groups. Preliminarily, the results suggested the presence of alterations in the gene expressions of the TP53, P21, BAX, BCL-2 and BCL-xL leading to loss of function in these genes, which affect the tumorigenesis of CTVT.


2018 ◽  
Author(s):  
Ke Ning ◽  
Wenlong Ning ◽  
Xiaoting Ning ◽  
Xueyan Wang ◽  
Fei Zhou

2020 ◽  
Author(s):  
YingJie Li ◽  
Dagang Guo ◽  
Yihong Zhang ◽  
Lin Wang ◽  
Tingting Sun ◽  
...  

Abstract In vitro patient tumor models such as patient-derived organoids (PDO) and conditionally reprogrammed (CR) cell culture are important for translational research and pre-clinical drug testing.In this study we present a personalized drug sensitivity test for late stage, potentially operable colorectal cancer (CRC) using patient-derived primary cell culture based on a new generation CR technology. We explored the clinical feasibility of using CR-based primary cell culture system to guide CRC chemotherapy, and established the correlation between in vitro drug sensitivity and patient clinical response.Our novel CR platform (termed i-CR) can be used to propagate primary colorectal tumor cells that represent individual patient tumors effectively by keeping the clonal heterogeneity and comparable drug responses.Therefore, our platform can be used to test and optimize therapeutic regimens pre-clinically, study cancer cell biology, and model tumor re-emergence to identify new targeted therapeutics from an effective personalized medicine standpoint.


Sign in / Sign up

Export Citation Format

Share Document